Maya Fayfman MD
Diabetes, Lipid Metabolism
Clinical Associate, Medicine, Tufts Medical Center
Join to View Full Profile
69 Jesse Hill Jr Drive SEAtlanta, GA 30303
Phone+1 404-616-1000
Dr. Fayfman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2013 - 2015
Tufts Medical CenterResidency, Internal Medicine, 2010 - 2013
Boston University School of MedicineClass of 2010
Certifications & Licensure
GA State Medical License 2015 - 2027
MA State Medical License Active through 2013
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Sitagliptin in Non-Diabetic Patients Undergoing General Surgery Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- A Real-World Study of Oral Antihyperglycemic Agents as Compared With Basal Insulin in Hospitalized Patients With Type 2 Diabetes.Maya Fayfman, Irit Hochberg, Michelle Magee, Ammar Rashied, Nataliya Chaudhry
Endocrine Practice. 2025-07-08 - 1 citationsIntelligent Care Management for Diabetic Foot Ulcers: A Scoping Review of Computer Vision and Machine Learning Techniques and Applications.Cynthia Baseman, Maya Fayfman, Marcos C Schechter, Sarah Ostadabbas, Gabriel Santamarina
Journal of Diabetes Science and Technology. 2025-05-01 - 5 citationsSingle-Cell Analysis of Debrided Diabetic Foot Ulcers Reveals Dysregulated Wound Healing Environment in Non-Hispanic Black Patients.Dahim Choi, Mojtaba Bakhtiari, William Pilcher, Chenbin Huang, Beena E Thomas
The Journal of Investigative Dermatology. 2025-03-01
Press Mentions
How Can Surgical Outcomes Be Improved for Black Patients?July 25th, 2022
Grant Support
- Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation (CARE-D-Foot-Nav), a randomized controlled trialEMORY UNIVERSITY2025–2030
- Randomized controlled trial of continuous glucose monitoring compared to point of care glucose testing following hospital discharge on 12-week diabetic foot ulcer healing ratesEMORY UNIVERSITY2023–2025
- Use of Non-Insulin Agents in Hospitalized Patients with Type 2 diabetes (T2D)EMORY UNIVERSITY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
